Who Owns PBM?

Psyence Biomedical Ltd. — Institutional Ownership & 13F Holdings

$7.00

-0.96 (-12.14%)

Market Cap

$49K

Shares Outstanding

19,019

Institutional Holders

8

Total Inst. Value

$273K

% of Float Held

2392.4%

QoQ Holder Change

Institutional data as of Q1 2025

New Positions

4

Closed Positions

8

Increased

4

Decreased

0

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1SABBY MANAGEMENT, LLCNew$154K256,700
2CITADEL ADVISORS LLC$45K75,318
3Virtu Financial LLC$22K36,482
4AdvisorShares Investments LLC$21K35,458
5UBS Group AG$20K33,559
6TWO SIGMA SECURITIES, LLCNew$8K12,941
7Stonehage Fleming Financial Services Holdings LtdNew$3K4,479
8MORGAN STANLEYNew$069

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold PBM?

As of Q1 2025, 8 institutional investors report holding PBM (Psyence Biomedical Ltd.) in their 13F filings.

What percentage of Psyence Biomedical Ltd. is owned by institutions?

Institutional investors hold approximately 2392.4% of Psyence Biomedical Ltd.'s float as reported in SEC 13F filings.

Which hedge fund owns the most PBM?

The largest institutional holder of PBM is SABBY MANAGEMENT, LLC with $154K in shares.

Are institutions buying or selling PBM?

This quarter, 4 institutions opened new positions in PBM and 8 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.